Monte Rosa Therapeutics, Inc. (GLUE) reported Q1 Revenue
Tweet
Share
E-mailGet Alerts GLUE Hot Sheet
Join SI Premium – FREE
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) reported Q1 Revenue for the quarter came in at $4.21 million versus the consensus estimate of $13.57 million.
For earnings history and earnings-related data on Monte Rosa Therapeutics, Inc. (GLUE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Musalem: strong growth and investment influencing bond market - CNBC
- Bessent says may raise bond buyback beyond $4 billion
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
